“Intradiscal oxygen-ozone chemonucleolysis versus microdiscectomy for lumbar disc herniation radiculopathy: a non–inferiority randomized control trial”
Authorship:
Alexis Kelekis, MDa, Giuseppe Bonaldi, MDb, Alessandro Cianfoni, MDc,d, Dimitrios Filippiadis, MDa, Pietro Scarone, MDc,d, Claudio Bernucci, MDb, David M. Hooper, PhDe, Hadas Benhabib, MDf, Kieran Murphy, MDf,*, Josip Buric, MDg
Institutional Affiliations:
aUniversity General Hospital Attikon, Athens, Haidari 12462, Greece
bAzienda Ospedaliera Papa Giovanni XXIII, Bergamo, Lombardia 24127, Italy
cDepartment of Neuroradiology, Neurocenter of Southern Switzerland, Lugano 6900, Switzerland
dDepartment of Interventional and Diagnostic Neuroradiology, Inselspital University Hospital of Bern, Bern 3008, Switzerland
eSpinafx Medical, Vaughan, Ontario, Canada
fToronto Western Hospital, University Health Network, Toronto, Canada
gCasa di Cura San Camillo, Forte dei Marmi, Lucca 55042, Italy
Explore our curated collection of peer-reviewed studies, clinical data, and medical literature supporting the efficacy of oxygen-ozone therapy in spinal care.
Filling the Therapeutic Gap in Herniated Disc Treatment: Inconsistencies in Diagnosis and Treatment Between Failed Conservative Care and Surgery.
Back pain is the #1 source of workdays lost to disability globally[1], with approximately 80% of adults experiencing a herniated disc in their lifetime[2] and an estimated prevalence of symptomatic herniated discs of 1-3% of patients[3]. The pain, loss of productivity, and related mental health deterioration resulting from chronic pain